Zimmer Biomet Holdings, Inc. (ZBH)
Automate Your Wheel Strategy on ZBH
With Tiblio's Option Bot, you can configure your own wheel strategy including ZBH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ZBH
- Rev/Share 41.7424
- Book/Share 64.431
- PB 1.5437
- Debt/Equity 0.5918
- CurrentRatio 1.9816
- ROIC 0.0495
- MktCap 19711137460.0
- FreeCF/Share 9.3732
- PFCF 10.6639
- PE 27.8127
- Debt/Assets 0.3256
- DivYield 0.0097
- ROE 0.056
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ZBH | William Blair | -- | Market Perform | -- | -- | Feb. 20, 2026 |
| Downgrade | ZBH | Goldman | Neutral | Sell | -- | $93 | Jan. 9, 2026 |
| Downgrade | ZBH | Raymond James | Outperform | Market Perform | -- | -- | Jan. 6, 2026 |
| Upgrade | ZBH | Evercore ISI | In-line | Outperform | -- | $210 | Jan. 5, 2026 |
| Downgrade | ZBH | Robert W. Baird | Outperform | Neutral | -- | $100 | Dec. 16, 2025 |
| Downgrade | ZBH | JP Morgan | Overweight | Neutral | -- | $100 | Nov. 6, 2025 |
| Initiation | ZBH | Rothschild & Co Redburn | -- | Buy | -- | $130 | Sept. 18, 2025 |
| Upgrade | ZBH | Roth Capital | Neutral | Buy | -- | $135 | July 15, 2025 |
| Upgrade | ZBH | JP Morgan | Neutral | Overweight | $125 | $128 | Dec. 17, 2024 |
| Initiation | ZBH | Wolfe Research | -- | Peer Perform | -- | -- | Sept. 10, 2024 |
News
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2026
Published: February 23, 2026 by: PRNewsWire
Sentiment: Neutral
WARSAW, Ind., Feb. 23, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2026.
Read More
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
Published: February 18, 2026 by: PRNewsWire
Sentiment: Neutral
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Feb. 18, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company's previously expressed "high confidence" in its 2025 revenue targets. The firm urges investors who suffered significant losses to submit your ZBH losses now.
Read More
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
Published: February 12, 2026 by: MarketBeat
Sentiment: Positive
More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable firms in the healthcare space can surprise with growth upon the release of a new blockbuster drug or medical device, and earnings periods are an opportunity for management to provide insight and commentary beyond what investors might expect from FDA notices of approvals, for example.
Read More
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript
Published: February 10, 2026 by: Seeking Alpha
Sentiment: Neutral
Zimmer Biomet Holdings, Inc. (ZBH) Q4 2025 Earnings Call Transcript
Read More
ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Zimmer Biomet beats Q4 earnings and revenue estimates, with sales up 10.9% and shares rising 1.4% pre-market despite margin contraction.
Read More
Zimmer (ZBH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Zimmer Biomet (ZBH) Q4 Earnings and Revenues Top Estimates
Published: February 10, 2026 by: Zacks Investment Research
Sentiment: Positive
Zimmer Biomet (ZBH) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.31 per share a year ago.
Read More
Unveiling Zimmer (ZBH) Q4 Outlook: Wall Street Estimates for Key Metrics
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Neutral
Evaluate the expected performance of Zimmer (ZBH) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Read More
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution
Published: February 04, 2026 by: PRNewsWire
Sentiment: Neutral
Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company's previously expressed "high confidence" in its 2025 revenue targets. The firm urges investors who suffered significant losses to submit your ZBH losses now and visit Hagens Berman's case page to view our latest investigation summary: www.hbsslaw.com/cases/zimmer-biomet-holdings-inc-zbh-investigation The investigation focuses on whether Zimmer Biomet senior management may have …
Read More
Zimmer Biomet to Report Q4 Earnings: Here's What to Expect
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.
Read More
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Neutral
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
ZBH Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and “Inconsistent” Execution
Published: January 23, 2026 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is investigating Zimmer Biomet Holdings, Inc. (NYSE: ZBH) following a series of disclosures that calls into question the reasonable basis for the company's previously expressed “high confidence” in its 2025 revenue targets. The firm urges investors who suffered significant losses to submit your ZBH losses now and visit Hagens Berman's case page to view our latest investigation summary: www.hbsslaw.com/cases/zimmer-biomet-holdings-inc-zbh-investigation The investigation focuses on whether Zimmer Biomet senior management may have misled investors regarding the stability of its international business.
Read More
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Published: January 15, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
How the OneStep Partnership Could Drive Growth for ZBH Stock
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Zimmer Biomet teams up with OneStep to integrate mobility analytics into mymobility, empowering surgeons and patients while advancing its connected care strategy.
Read More
Why Is Zimmer (ZBH) Up 5.3% Since Last Earnings Report?
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Read More
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Published: December 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc. - ZBH
Published: November 20, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Published: November 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) on behalf of investors concerning the Company's possible violations of federal securities laws.
Read More
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman
Published: November 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy. The developments and significant market reaction have prompted shareholder rights law firm Hagens Berman to open an investigation into whether Zimmer Biomet may have violated the federal securities laws.
Read More
Zimmer Biomet Holdings, Inc. (ZBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Published: November 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
BENSALEM, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company's possible violations of federal securities laws.
Read More
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: November 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company's possible violations of the federal securities laws.
Read More
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript
Published: November 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Zimmer Biomet Holdings, Inc. ( ZBH ) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Company Participants Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division All right. Great. Thanks for joining us for our next session here at the Jefferies Healthcare Conference.
Read More
Zimmer Biomet Holdings (ZBH) Faces Investor Scrutiny Amid Emerging Markets Distributor Orders Cancelation, Reduced Top-Line Revenue Forecast -- Hagens Berman
Published: November 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy.
Read More
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Published: November 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: November 13, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happ.
Read More
Time To Buy Zimmer Biomet Stock?
Published: November 06, 2025 by: Forbes
Sentiment: Positive
Zimmer Biomet (ZBH) stock ought to be on your radar. Here's why – it is presently trading within the support range ($83.17 – $91.93), levels from which it has rebounded significantly in the past.
Read More
Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Negative
Zimmer Biomet's Q3 EPS beats expectations, but a revenue miss and trimmed outlook send shares sliding in pre-market trading.
Read More
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2025 Earnings Call Transcript
Published: November 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Zimmer Biomet Holdings, Inc. ( ZBH ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants David DeMartino - Senior Vice President of Investor Relations Ivan Tornos - President, CEO & Chairman of the Board Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain Conference Call Participants Robert Marcus - JPMorgan Chase & Co, Research Division Travis Steed - BofA Securities, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Patrick Wood - Morgan Stanley, Research Division Larry Biegelsen - Wells Fargo Securities, …
Read More
Zimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
About Zimmer Biomet Holdings, Inc. (ZBH)
- IPO Date 2001-07-25
- Website https://www.zimmerbiomet.com
- Industry Medical - Devices
- CEO Ivan Tornos
- Employees 17000